Free Trial
Boris Peaker

Boris Peaker Analyst Performance

Managing Director at JonesTrading

Boris Peaker is a stock analyst at JonesTrading in the medical sector, covering 24 publicly traded companies. Over the past year, Boris Peaker has issued 2 stock ratings, including buy and hold recommendations. While full access to Boris Peaker's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Boris Peaker's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
102 Last 11 Years
Buy Recommendations
76.47% 78 Buy Ratings
Companies Covered
24 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy76.5%78 ratings
Hold23.5%24 ratings
Sell0.0%0 ratings

Out of 102 total stock ratings issued by Boris Peaker at JonesTrading, the majority (76.5%) have been Buy recommendations, followed by 23.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
95.8% of companies on NASDAQ
23 companies
NYSE
4.2% of companies on NYSE
1 company

Boris Peaker, an analyst at JonesTrading, currently covers 24 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
24 companies
100.0%

Boris Peaker of JonesTrading specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
11 companies
45.8%
MED - DRUGS
5 companies
20.8%
PHARMACEUTICAL PREPARATIONS
4 companies
16.7%
BIOTECHNOLOGY
2 companies
8.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC
1 company
4.2%
MED PRODUCTS
1 company
4.2%

Boris Peaker's Ratings History at JonesTrading

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Janux Therapeutics, Inc. stock logo
JANX
Janux Therapeutics
4/28/2026Lower Price Target$14.37$28.00Buy
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
4/14/2026Initiated Coverage$15.26$18.00Hold